Posts Tagged ‘drug importation’
HHS comments come in overwhelmingly against Canadian drug importation proposal
Yesterday ended a 78-day comment period for the White House’s proposal to import medicine from Canada. In all, over 1,000 comments were filed. Overwhelmingly, these comments opposed the proposed rule or expressed skepticism that the rule could meet the two requirements listed in the Medicare Modernization Act of 2003: be safe and save consumers money. In fact, when you read the comments, it is clear that this policy is overwhelming opposed by experts on the issues of economics and medicine safety.
[...]Former FDA Associate Commissioner Warns of the “Massive Safety Risks of Importation”
Source: Twitter This editorial by Peter J. Pitts was published in The Times Weekly on March 3, 2020. Mr. Pitts is president of the Center for Medicine in the Public Interest and a former FDA associate commissioner. Keep Canadian drugs out of U.S. medicine cabinets The Trump administration recently proposed two rules that would allow…
[...]FDA Worked With Indian Government To Seize 500 Counterfeit Drug Shipments in January
The U.S. Food and Drug Administration (FDA) has just announced a successful joint operation with the Government of India targeting counterfeit prescription drugs, counterfeit over-the-counter medications, fake medical devices, and misbranded dietary supplements containing harmful ingredients.
[...]Security Breach Illustrates Another Danger of Fake Online Pharmacies
Planet Drugs Direct, an online pharmacy based in Winnipeg, Canada, has announced a data breach. Hackers broke into their servers, exposing customers’ names, medical details, and contact and banking information. Legitscript is unequivocal in calling Planet Drugs Direct a “Rogue Internet Pharmacy,” their worst rating for online pharmacies, accusing them of violating state and federal laws.
[...]Canadian health law experts predict: Canada won’t end up as the drugstore to the U.S.
This editorial by David C. Rosenbaum and Dara Jospé was published in the Financial Post on January 16, 2020. Rosenbaum is a partner of the law firm Fasken. Jospé is an associate for the same company.
[...]Academic Warns That State Drug Importation Proposals Threaten Patients and Innovation
This editorial by Dr. Kristina M. L. Acri née Lybecker was published in IP Watchdog on January 2, 2020. Dr. Acri is an Associate Professor of Economics at Colorado College in Colorado Springs, and Chair of the Department of Economics and Business.
[...]Canadian Doctors, Pharmacists, Patient Groups and Government Representatives Consider State Importation Proposals Unfeasible
In spite of recent efforts by legislators in Florida, Maine, Colorado, and elsewhere, Canadian patient groups are vocally opposing pending legislation that proposes importing prescription medications from the Canadian drug supply. Paul Blanchard of the New Brunswick Pharmacists’ Association told CBC News, “The country’s pharmacists association has been talking to the federal government … to make sure that the federal government and Canada is aware that the Americans are literally knocking on our door.”
[...]Two Studies Confirm Drug Importation Would Decimate The Canadian Drug Supply
Two new studies recently published in Canadian Health Policy each reached the same conclusion: legalizing drug importation in the U.S. would cause catastrophic damage to the Canadian drug supply…
[...]Pharmacy professor: buying prescription drugs from Canada “risky in terms of quality and safety”
This editorial by C. Michael White was published in The Conversation on September 27, 2019. White is a professor and head of the Department of Pharmacy Practice for the University of Connecticut.
[...]Partnership for Safe Medicines 2019 Congressional Briefings (September 24, 2019)
On Tuesday, September 24, 2019, counterfeit medication victims and their families, American and Canadian patient groups, local and federal law enforcement, and other experts in the fight against counterfeit medicines gathered in Washington, D.C. to discuss how importation proposals threaten to trigger drug shortages in Canada while wreaking havoc on medication safety for U.S. patients.
[...]